1-6 of 6
braf gene
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

High-risk LCH in infants is serially transplantable in a xenograft model but responds durably to targeted therapy

Lynn H. Lee, Christa Krupski, Jason Clark, Mark Wunderlich, Robert B. Lorsbach, Michael S. Grimley, Matthew Burwinkel, Adam Nelson, Ashish R. Kumar
Journal: Blood Advances
Blood Adv (2020) 4 (4): 717–727.
https://doi.org/10.1182/bloodadvances.2019032367
Published: 2020
Includes: Supplemental data
Journal Articles

Circulating CD1c + myeloid dendritic cells are potential precursors to LCH lesion CD1a + CD207 + cells

Karen Phaik Har Lim, Paul Milne, Michael Poidinger, Kaibo Duan, Howard Lin, Naomi McGovern, Harshal Abhyankar, Daniel Zinn, Thomas M. Burke, Olive S. Eckstein, Rikhia Chakraborty, Amel Sengal, Brooks Scull, Evan Newell, Miriam Merad, Kenneth L. McClain, Tsz-Kwong Man, Florent Ginhoux, Matthew Collin, Carl E. Allen
Journal: Blood Advances
Blood Adv (2020) 4 (1): 87–99.
https://doi.org/10.1182/bloodadvances.2019000488
Published: 2020
Includes: Supplemental data
Journal Articles

BRAF -V600E–mutated Rosai-Dorfman-Destombes disease and Langerhans cell histiocytosis with response to BRAF inhibitor

Clinical Trials & Observations
Rosemarie Mastropolo, Allison Close, Steven W. Allen, Kenneth L. McClain, Scott Maurer, Jennifer Picarsic
Journal: Blood Advances
Blood Adv (2019) 3 (12): 1848–1853.
https://doi.org/10.1182/bloodadvances.2019000093
Published: 2019
Includes: Supplemental data
Journal Articles

Long-term disease control of Langerhans cell histiocytosis using combined BRAF and MEK inhibition

Clinical Trials & Observations
Gil Awada, Teofila Seremet, Karel Fostier, Hendrik Everaert, Bart Neyns
Journal: Blood Advances
Blood Adv (2018) 2 (16): 2156–2158.
https://doi.org/10.1182/bloodadvances.2018021782
Published: 2018
Journal Articles

BRAF V600E accelerates disease progression and enhances immune suppression in a mouse model of B-cell leukemia

Yo-Ting Tsai, Aparna Lakshmanan, Amy Lehman, Bonnie K. Harrington, Fabienne McClanahan Lucas, Minh Tran, Ellen J. Sass, Meixiao Long, Alan D. Flechtner, Florinda Jaynes, Krista La Perle, Vincenzo Coppola, Gerard Lozanski, Natarajan Muthusamy, John C. Byrd, Michael R. Grever, David M. Lucas
Journal: Blood Advances
Blood Adv (2017) 1 (24): 2147–2160.
https://doi.org/10.1182/bloodadvances.2017006593
Published: 2017
Includes: Supplemental data
Journal Articles

The clinical spectrum of Erdheim-Chester disease: an observational cohort study

Clinical Trials & Observations
Juvianee I. Estrada-Veras, Kevin J. O’Brien, Louisa C. Boyd, Rahul H. Dave, Benjamin H. Durham, Liqiang Xi, Ashkan A. Malayeri, Marcus Y. Chen, Pamela J. Gardner, Jhonell R. Alvarado Enriquez, Nikeith Shah, Omar Abdel-Wahab, Bernadette R. Gochuico, Mark Raffeld, Elaine S. Jaffe, William A. Gahl
Journal: Blood Advances
Blood Adv (2017) 1 (6): 357–366.
https://doi.org/10.1182/bloodadvances.2016001784
Published: 2017
Includes: Supplemental data